< Back to previous page
Researcher
Kristel Van Calsteren
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Woman and Child (Division)
Member
From1 Apr 2013 → Today - Department of Development and Regeneration (Department)
Member
From1 Oct 2012 → 31 Mar 2013 - Gynaecological Oncology (Division)
Member
From1 Nov 2009 → 31 Aug 2011
Projects
1 - 10 of 14
- Medication use and safety related to the pharmacological management of immune-mediated inflammatory diseases before, during and after pregnancyFrom18 Sep 2025 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Medication safety and patient perspectives related to the treatment of immune-mediated inflammatory diseases in pregnancyFrom1 Oct 2024 → 30 Sep 2025Funding: Own budget, for example: patrimony, inscription fees, gifts
- Perinatal depression in (pregnant) mothers: 'From prevalence to prevention' – A precision medicine approach within a public health perspectiveFrom1 Oct 2022 → TodayFunding: BOF - projects, Fund Recuperation Fiscal Exemption
- The development and validation of a prototype of a Belgian data registration system on medication use during pregnancy and lactation (BELpREG-project)From1 Jan 2021 → 31 Dec 2022Funding: IOF - technology validation in lab
- CANCER IN PREGNANCY: LONGITUDINAL FOLLOW-UP OF CHILD DEVELOPMENT AFTER PRENATAL EXPOSURE TO MATERNAL CANCERFrom1 Oct 2020 → 6 Nov 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
- The impact of an international advisory board on the management of cancer during pregnancyFrom11 Mar 2020 → 10 Jan 2025Funding: Own budget, for example: patrimony, inscription fees, gifts
- IMPLEMENTATION OF GENOME-WIDE CELL-FREE DNA SEQUENCING FOR THE EARLY IDENTIFICATION AND EFFICIENT MANAGEMENT OF HIGH-RISK PREGNANCIESFrom1 Nov 2019 → 10 Oct 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Cancer treatment during pregnancy.From1 Jan 2019 → 30 Sep 2025Funding: Nonprofit institution or equivalents
- Antenatal Sildenafil To Prevent Pulmonary hypertension in congenital diaphragmatic Hernia (SToP-PH): moving from bench to clinical practiceFrom1 Oct 2017 → 30 Sep 2019Funding: IOF - Industrial Research Fund
- PROGNOSTIC FACTORS FOR OBSTETRIC AND ONCOLOGICAL OUTCOME IN PREGNANT WOMEN WITH CANCER Chemotherapy in pregnancy: from fetal safety to maternal efficacyFrom20 Sep 2017 → 16 Jun 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 218
- Vulvar and vaginal cancer during pregnancy: A pooled analysis of 15 cases from the International Network on Cancer, Infertility and Pregnancy and review of the literature(2025)Published in: Acta Obstetricia et Gynecologica ScandinavicaISSN: 0001-6349Issue: 11Volume: 104Pages: 2187 - 2199
- Abdominal shielding not recommended for diagnostic imaging with ionising radiation during pregnancy.(2025)Published in: The Lancet OncologyISSN: 1470-2045Issue: 11Volume: 26Pages: 1413 - 1416
- Hearing assesment in children after intrauterine exposure to platinum-based treatment of pregnant cancer patients: A study from the International Network on Cancer, Infertility and Pregnancy(2025)Published in: BMC PediatricsISSN: 1471-2431Issue: 1Volume: 25
- Reply to the Letter to the Editor by Szarpak et al.(2025)Published in: ANNALS OF ONCOLOGYISSN: 0923-7534Issue: 10Volume: 36
- ESGO/INCIP Guidelines for the management of patients with gynecological cancers during pregnancy(2025)Published in: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCERISSN: 1048-891XIssue: 9Volume: 35
- Long-term development of 12-and 15-year-old offspring after maternal cancer diagnosis during pregnancy: a prospective multicentre cohort study(2025)Published in: ANNALS OF ONCOLOGYISSN: 0923-7534Issue: 9Volume: 36
- Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells(2025)Published in: Cancer DiscoveryISSN: 2159-8274Issue: 5Volume: 15Pages: 903 - 912
- Persistent Uninterpretable or Failed Prenatal Cell-Free DNA Screening Indicates a High-Risk Pregnancy and is Associated With Biological Factors Interfering With cfDNA-Analysis: A Prospective Cohort Study(2025)Published in: Prenatal DiagnosisISSN: 0197-3851Issue: 5Volume: 45Pages: 581 - 590
- The Development of a Multidisciplinary Care Pathway for Patients with Inflammatory Bowel Disease Before, During and After Pregnancy(2025)Published in: Journal of Clinical MedicineISSN: 2077-0383Issue: 8Volume: 14
- Preimplantation genetic testing for hereditary angioedema as a potential dominant cost-effective intervention(2025)Published in: Journal of Allergy and Clinical Immunology-in PracticeISSN: 2213-2198Issue: 3Volume: 13
Patents
1 - 1 of 1